To validate these findings we analyzed 175 ovarian cancer samples from Groningen [23] and 49 samples from Bergen and again confirmed that HOTAIR expression is a poor prognostic factor specifically in carboplatin-treated patients (Fig. 1c, d; Additional files 9 and 10). The gene discussed is HOTAIR; the disease is ovarian carcinoma.